Avsar.

Healthcare · Pharmaceuticals

Abbott India Ltd (ABBOTINDIA)

₹28,005.00

Mkt cap
₹59,511 Cr
P/E ratio
38.50
P/B
12.46
Div yield
1.87%
ROE
34.40%
ROCE
44.80%
EPS (TTM)
₹727.40
Book value
₹2,247
52W range
25,180–35,195
Sector
Healthcare

Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. [1] It was established in 1944. [2]

NSE ABBOTINDIABSE 500488www.abbott.co.in
Health check
Constructive
ValuationFair
ProfitabilityStrong
GrowthModerate
TechnicalsNeutral
52-week range
−20.43% from high
₹28,005
₹25,180+11.22% from low₹35,195
Current
₹28,005.00
Prev close
₹28,000.00
Day
+0.02%
Price performance
1D
+0.02%
1W
−0.95%
1M
+9.46%
3M
+11.22%
6M
+2.92%
1Y
−18.03%
YTD
−0.43%

Financials

F
Revenue, profit & margin
P/E ratio
38.5×
ABBOTINDIA is 13% above the sector median of 34.0×
ABBOTINDIA38.5×
Sector median34.0×
 Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Trend
Sales1,3431,4791,4941,4371,4391,5581,6331,6141,6051,7381,7571,7241,710
Expenses1,0631,1241,1131,0491,1091,1671,1941,1781,1761,2931,2551,2611,229
Operating Profit280355381388330391439436429446502463481
OPM %21%24%25%27%23%25%27%27%27%26%29%27%28%
Other Income50565656816760727673707076
Interest4333332246856
Depreciation17171818181818181819191919
Profit before tax308390415422390437479488483493546509531
Tax %25%26%25%26%26%25%25%26%24%26%24%26%26%
Net Profit231290313311287328359361367366415376395
EPS in Rs108.91136.59147.27146.35135.09154.36168.76169.78172.73172.18195.43176.93185.86
Raw PDF

Earnings

EResults dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

CLast 6 months
KindValueEx-dateRecord
dividend
Dividend - Rs 525 Per Share & Special Dividend Rs 131 Per Share
525.0024 Jul '2624 Jul '26

Shareholding

Sas of Jun 2026
74.99%Promoter
Promoters74.99%
FIIs0.38%0.11
DIIs8.77%0.16
Public15.85%0.04
Ownership trend

Peers

P8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,941.1037.484,65,7350.82%2,710+13.58%14,612+12.76%20.53%
Divi's Lab.₹7,248.5073.361,92,4250.41%751+13.44%2,831+9.52%21.97%
Torrent Pharma.₹4,961.5086.111,88,7200.77%364−20.58%4,197+41.84%15.19%
Cipla₹1,410.6031.841,13,9550.92%786−39.19%7,119+2.33%15.49%
Zydus Lifesci.₹1,108.7020.381,10,5930.09%1,341+21.92%7,587+16.22%21.14%
Lupin₹2,370.5019.061,08,3870.76%1,469+101.49%7,475+31.89%29.93%
Mankind Pharma₹2,507.2051.441,03,5460.04%559+34.23%3,443+11.81%13.53%
Abbott India₹28,005.0038.4759,5111.87%395+7.60%1,710+6.54%44.80%
Median: 157 Co.₹432.0534.031,9780.10%15+28.10%176+17.66%15.10%

Filings

D
Annual reports15
Financial Year 2026bseFinancial Year 2025bseFinancial Year 2024bseFinancial Year 2023bseFinancial Year 2022bseFinancial Year 2021bseFinancial Year 2020bseFinancial Year 2019bseFinancial Year 2018bseFinancial Year 2017bseFinancial Year 2016bseFinancial Year 2015bseFinancial Year 2014bseFinancial Year 2012bseFinancial Year 2011bse
Concall transcripts3
TranscriptSep 2022RECSep 2022TranscriptJun 2021
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 20 Jul - Newspaper Advertisement for Eighty-second Annual General Meeting, E-voting facility and Dividend.Communication Providing The Weblink Including Path Of Annual Report. 20 Jul - Abbott India shared the 2025-26 annual report web-link under SEBI Regulation 36.Business Responsibility and Sustainability Reporting (BRSR) 20 Jul - Abbott India submitted FY2025-26 BRSR with independent assurance statement on July 20, 2026.Annual General Meeting On August 13, 2026. 20 Jul - Abbott India AGM on Aug 13, 2026; proposes ₹525 final and ₹131 special dividend.Reg. 34 (1) Annual Report. 20 Jul